National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

tiazofurin
A synthetic nucleoside analogue with antineoplastic activity. Tiazofurin (TR) is anabolized intracellularly to an analogue of NAD, tiazole-4-carboxamide adenine dinucleotide (TAD), a potent inhibitor of IMP dehydrogenase (IMPDH); IMPDH is the rate-limiting enzyme for de novo purine synthesis. Inhibition of IMPDH results in reduced levels of guanylates, resulting in the inhibition tumor cell growth in vitro and in vivo. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

US brand name:Riboxamide
Abbreviation:TCAR
Chemical structure names:
  • 2-beta-D-ribofuranosyl-4-thiazolecarboxamide
  • 2-beta-D-ribofuranosylthiazole-4-carboxamide



Previous:thymopentin, Thyrogen, thyroxine, Thytropar, tiacumicin B
Next:tibolone, ticilimumab, Tifosyl, timonacic, tin ethyl etiopurpurin

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov